rivastigmine [extracellular region]

Stable Identifier
R-ALL-9635054
Type
ChemicalDrug
Compartment
extracellular region
Locations in the PathwayBrowser
for Species:
Expand all
Literature References
PubMed ID Title Journal Year
12139367 The tolerability and safety of cholinesterase inhibitors in the treatment of dementia

Inglis, F

Int J Clin Pract Suppl 2002
10066203 Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial

Rösler, M, Anand, R, Cicin-Sain, A, Gauthier, S, Agid, Y, Dal-Bianco, P, Stähelin, HB, Hartman, R, Gharabawi, M

BMJ 1999
15590953 Rivastigmine for dementia associated with Parkinson's disease

Emre, M, Aarsland, D, Albanese, A, Byrne, EJ, Deuschl, G, De Deyn, PP, Durif, F, Kulisevsky, J, van Laar, T, Lees, A, Poewe, W, Robillard, A, Rosa, MM, Wolters, E, Quarg, P, Tekin, S, Lane, R

N. Engl. J. Med. 2004
26393402 Rivastigmine for Alzheimer's disease

Birks, JS, Chong, LY, Grimley Evans, J

Cochrane Database Syst Rev 2015
18581467 Rivastigmine versus placebo in hyperhomocysteinemic Parkinson's disease dementia patients

Barone, P, Burn, DJ, van Laar, T, Hsu, C, Poewe, W, Lane, RM

Mov. Disord. 2008
External Reference Information
External Reference
rivastigmine [Guide to Pharmacology:6602]
Participates
as a member of
Disease
Name Identifier Synonyms
Alzheimer's disease DOID:10652 AD, Alzheimers dementia, Alzheimer disease
Parkinson's disease DOID:14330 Parkinson disease, paralysis agitans
Cross References
Mondo
ChEBI
Cite Us!